Teva Fails To Block Paddock's Cenestin ANDA
A federal judge has ruled that Teva Women's Health Inc.'s actions during the patent application process have doomed its infringement suit against Paddock Laboratories Inc. over a generic version of menopause...To view the full article, register now.
Already a subscriber? Click here to view full article